Please don't hesitate to contact us if you have any questions or other inquiries.

Solving the Translational Drug Development Gap, from Fibrotic Mechanisms to Clinically Successful Therapeutics

The summit focuses on solving the translational drug development gap, from fibrotic mechanisms to clinically successful therapeutics.

Dr. Morten Asser Karsdal, CEO of Nordic Bioscience A/S, will be presenting his topic “Extracellular Matrix Remodeling is the Common Denominator in all Fibrotic Diseases“ at the event. Tune in on 2 November, 11.30 EST / 8.30 PST.

 Amongst other insights, Dr. Karsdal will talk about:

  • Fibroblast and the importance in fibro-inflammatory disorders and the quantification thereof
  • Assessing ECM remodeling non-invasively can be used as prognostic and pharmacodynamic biomarkers
  • FACIT collagens: what are they and why are they important?

 

 Nordic Bioscience is a proud sponsor of the 5th Annual Drug Development Summit.

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information to provide the best possible experience. By using our website, you agree to our Privacy Policy and our cookies usage. Cookie Policy Privacy Statement